Concepedia

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Geneviève Laureys, Josef Mališ,

The Lancet Oncology · 2017 · 348 citations · 30 references

DOIFull text

Open access

Concepts

References

30

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

The Annals of Statistics · 1988 · 5K citations · Full text

, , +15

The Statistical Analysis of Failure Time Data

John P. Klein · Technometrics · 1982 · 2.2K citations

, , +14

Association of Multiple Copies of the N-<i>myc</i>Oncogene with Rapid Progression of Neuroblastomas

Robert C. Seeger, Garrett M. Brodeur, Harland N. Sather et al. · New England Journal of Medicine · 1985 · 2K citations

, , +17

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

, , +14

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-<i>cis</i>-Retinoic Acid: A Children's Oncology Group Study

Katherine K. Matthay, C. Patrick Reynolds, Robert C. Seeger et al. · Journal of Clinical Oncology · 2009 · 856 citations

, , +6